Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks.

Abstract

BACKGROUND Postnatal corticosteroids were widely used in the 1990s in an attempt to reduce the incidence of bronchopulmonary dysplasia. However, high rates of short-term adverse effects and impaired neurodevelopmental outcomes were seen. In early 2002, a joint statement of the American Academy of Pediatrics and Canadian Paediatric Society called for… (More)

Topics

  • Presentations referencing similar topics